Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maté Ongenaert

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Oncotarget|December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastomaAnneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
Iscience|March 10, 2025
JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-GNataša Obermajer, Adam Zwolak, Kelly van de Ven, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Oncotarget|December 10, 2015
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastomaAnneleen Decock, Maté Ongenaert, Robrecht Cannoodt, et al.
Iscience|March 10, 2025
JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-GNataša Obermajer, Adam Zwolak, Kelly van de Ven, et al.
Pageof 3